The Cooper Companies, Inc. (LON:0I3I)

Market Cap	9.06B -14.4%
Revenue (ttm)	3.15B +4.7%
Net Income	423.66M +39.8%
EPS	2.18 +42.4%
Shares Out	n/a
PE Ratio	21.76
Forward PE	13.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151
Open	63.62
Previous Close	63.62
Day's Range	62.56 - 64.00
52-Week Range	51.02 - 89.11
Beta	0.83
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 3, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I3I

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error